Functional implications of novel human acid sphingomyelinase splice variants

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Rhein, Cosima ^a   Tripal, Philipp ^a   Seebahn, Angela ^b   Konrad, Alice ^a   Kramer, Marcel ^d   Nagel, Christine ^a   Kemper, Jonas ^a   Bode, Jens ^a   Mühle, Christiane ^a   Gulbins, Erich ^c   Reichel, Martin ^a   Becker, Cord Michael ^b   Kornhuber, Johannes ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID SPHINGOMYELINASE 5; ACID SPHINGOMYELINASE 6; ACID SPHINGOMYELINASE 7; PROTEIN VARIANT; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; ACID SPHINGOMYELINASE 1; ACID SPHINGOMYELINASE-1; CERAMIDE; ISOENZYME; OLIGONUCLEOTIDE; PRIMER DNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; SEQUENCE ALIGNMENT; AMINO ACID SEQUENCE; BIOLOGY; CAPILLARY ELECTROPHORESIS; GENE STRUCTURE; GENETICS; HELA CELL; MASS SPECTROMETRY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; WESTERN BLOTTING;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CERAMIDES; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; DNA PRIMERS; ELECTROPHORESIS, CAPILLARY; GENE COMPONENTS; HELA CELLS; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84860444286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035467     Document Type: Article

References (52)

1. Quintern LE, Weitz G, Nehrkorn H, Tager JM, Schram AW, et al. (1987) Acid sphingomyelinase from human urine: purification and characterization. Biochim Biophys Acta 922: 323-336.
2. Spiegel S, Merrill AH Jr, (1996) Sphingolipid metabolism and cell growth regulation. FASEB J 10: 1388-1397.
3. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, et al. (1998) Sphingosine-1-phosphate in cell growth and cell death. Ann N Y Acad Sci 845: 11-18.
4. Brady RO, Kanfer JN, Mock MB, Fredrickson DS, (1966) The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc Natl Acad Sci U S A 55: 366-369.
5. He X, Huang Y, Li B, Gong CX, Schuchman EH, (2008) Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging. Epub 2008 Jun 10.
6. Mikati MA, Zeinieh M, Habib RA, El Hokayem J, Rahmeh A, et al. (2008) Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus. Epilepsy Res 81: 161-166.
7. Reichel M, Greiner E, Richter-Schmidinger T, Yedibela O, Tripal P, et al. (2010) Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence. Alcohol Clin Exp Res 34: 46-50.
8. Kornhuber J, Medlin A, Bleich S, Jendrossek V, Henkel AW, et al. (2005) High activity of acid sphingomyelinase in major depression. J Neural Transm 112: 1583-1590.
9. Lin T, Genestier L, Pinkoski MJ, Castro A, Nicholas S, et al. (2000) Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J Biol Chem 275: 8657-8663.
10. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, et al. (1997) Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186: 1831-1841.
11. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, et al. (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297.
12. Rebillard A, Rioux-Leclercq N, Muller C, Bellaud P, Jouan F, et al. (2008) Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage. Oncogene 27: 6590-6595.
13. Garcia-Ruiz C, Colell A, Mari M, Morales A, Calvo M, et al. (2003) Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111: 197-208.
14. Murate T, Suzuki M, Hattori M, Takagi A, Kojima T, et al. (2002) Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line. J Biol Chem 277: 9936-9943.
15. Langmann T, Buechler C, Ries S, Schaeffler A, Aslanidis C, et al. (1999) Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation. J Lipid Res 40: 870-880.
16. Wu J, Cheng Y, Jonsson BA, Nilsson A, Duan RD, (2005) Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells. J Lipid Res 46: 1944-1952.
17. Lecka-Czernik B, Moerman EJ, Jones RA, Goldstein S, (1996) Identification of gene sequences overexpressed in senescent and Werner syndrome human fibroblasts. Exp Gerontol 31: 159-174.
18. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, et al. (2008) Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 283: 13538-13548.
19. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I, (1998) The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273: 18250-18259.
20. Qiu H, Edmunds T, Baker-Malcolm J, Karey KP, Estes S, et al. (2003) Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J Biol Chem 278: 32744-32752.
21. Zeidan YH, Hannun YA, (2007) Activation of acid sphingomyelinase by protein kinase Cdelta-mediated phosphorylation. J Biol Chem 282: 11549-11561.
22. Quintern LE, Schuchman EH, Levran O, Suchi M, Ferlinz K, et al. (1989) Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J 8: 2469-2473.
23. Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ, (1991) Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem 266: 8531-8539.
24. Gulbins E, Kolesnick R, (2000) Measurement of sphingomyelinase activity. Methods Enzymol 322: 382-388.
25. Spassieva SD, Rahmaniyan M, Bielawski J, Clarke CJ, Kraveka JM, et al. (2012) Cell density dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells. J Lipid Res. [Epub 2012 Feb 29].
26. Grabowski PJ, Black DL, (2001) Alternative RNA splicing in the nervous system. Prog Neurobiol 65: 289-308.
27. Xu Q, Modrek B, Lee C, (2002) Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 30: 3754-3766.
28. Kaufer D, Friedman A, Seidman S, Soreq H, (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393: 373-377.
29. Pick M, Flores-Flores C, Soreq H, (2004) From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses. Ann N Y Acad Sci 1018: 85-98.
30. Truman JP, Al Gadban MM, Smith KJ, Hammad SM, (2011) Acid sphingomyelinase in macrophage biology. Cell Mol Life Sci 68: 3293-3305.
31. Calarco JA, Xing Y, Caceres M, Calarco JP, Xiao X, et al. (2007) Global analysis of alternative splicing differences between humans and chimpanzees. Genes Dev 21: 2963-2975.
32. Skandalis A, Frampton M, Seger J, Richards MH, (2010) The adaptive significance of unproductive alternative splicing in primates. RNA 16: 2014-2022.
33. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, et al. (2002) Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420: 563-573.
34. Zavolan M, Kondo S, Schonbach C, Adachi J, Hume DA, et al. (2003) Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome. Genome Res 13: 1290-1300.
35. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, et al. (2005) Function of alternative splicing. Gene 344: 1-20.
36. Levran O, Desnick RJ, Schuchman EH, (1991) Niemann-Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients. J Clin Invest 88: 806-810.
37. Levran O, Desnick RJ, Schuchman EH, (1992) Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients. Blood 80: 2081-2087.
38. Levran O, Desnick RJ, Schuchman EH, (1993) Type A Niemann-Pick disease: a frameshift mutation in the acid sphingomyelinase gene (fsP330) occurs in Ashkenazi Jewish patients. Hum Mutat 2: 317-319.
39. Takahashi T, Desnick RJ, Takada G, Schuchman EH, (1992) Identification of a missense mutation (S436R) in the acid sphingomyelinase gene from a Japanese patient with type B Niemann-Pick disease. Hum Mutat 1: 70-71.
40. Takahashi T, Suchi M, Desnick RJ, Takada G, Schuchman EH, (1992) Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms. J Biol Chem 267: 12552-12558.
41. Ferlinz K, Hurwitz R, Sandhoff K, (1991) Molecular basis of acid sphingomyelinase deficiency in a patient with Niemann-Pick disease type A. Biochem Biophys Res Commun 179: 1187-1191.
42. Ferlinz K, Hurwitz R, Weiler M, Suzuki K, Sandhoff K, et al. (1995) Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease. Am J Hum Genet 56: 1343-1349.
43. Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH, (2002) The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype/phenotype correlations. Am J Hum Genet 71: 1413-1419.
44. Rodriguez-Pascau L, Gort L, Schuchman EH, Vilageliu L, Grinberg D, et al. (2009) Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients. Hum Mutat 30: 1117-1122.
45. Auwerx J, (1991) The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47: 22-31.
46. Kramer M, Huse K, Menzel U, Backhaus O, Rosenstiel P, et al. (2011) Constant splice-isoform ratios in human lymphoblastoid cells support the concept of a splico-stat. Genetics 187: 761-770.
47. Lehner M, Bailo M, Stachel D, Roesler W, Parolini O, et al. (2007) Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha. Leuk Res 31: 1729-1735.
48. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, et al. (2010) MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 11: 74.
49. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
50. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
51. Schiller J, Suss R, Arnhold J, Fuchs B, Lessig J, et al. (2004) Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res 43: 449-488.
52. Löhmann C, Schachmann E, Dandekar T, Villmann C, Becker CM, (2010) Developmental profiling by mass spectrometry of phosphocholine containing phospholipids in the rat nervous system reveals temporo-spatial gradients. J Neurochem 114: 1119-1134.